Camptothecin analogues: studies from the Johns Hopkins Oncology Center. (Q54223165)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Camptothecin analogues: studies from the Johns Hopkins Oncology Center.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7520844

Camptothecin analogues: studies from the Johns Hopkins Oncology Center. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7520844

Scott H Kaufmann

4

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7520844

author name string

W J Slichenmyer

1

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7520844

E K Rowinsky

2

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7520844

L B Grochow

3

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7520844

R C Donehower

5

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7520844

publication date

1 January 1994

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7520844

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7520844

34 Suppl

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7520844

S53-7

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7520844

Phase I Clinical and Pharmacology Study of Topotecan Given Daily for 5 Consecutive Days to Patients With Advanced Solid Tumors, With Attempt at Dose Intensification Using Recombinant Granulocyte Colony-Stimulating Factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/7520844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I

1 reference

https://pubmed.ncbi.nlm.nih.gov/7520844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/7520844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA topoisomerase poisons as antitumor drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/7520844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of topoisomerase modulators on cisplatin cytotoxicity in human ovarian carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7520844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ATP/Mg2+-dependent binding of vincristine to the plasma membrane of multidrug-resistant K562 cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7520844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7520844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of CPT-11 in combination with other anti-cancer agents in culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/7520844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7520844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The current status of camptothecin analogues as antitumor agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/7520844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/7520844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogue.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7520844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7520844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trials with the topoisomerase I inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7520844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of topotecan in patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7520844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00684864

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7520844

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7520844

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54223165&oldid=2212391442"